Evaluation of Functional Outcomes and OCT-Biomarkers after Intravitreal Dexamethasone Implant for Postoperative Cystoid Macular Edema in Vitrectomized Eyes.
Sigrid FreissingerEfstathios VounotrypidisArmin WolfKarsten Ulrich KortuemMehdi ShajariFilippos SakkiasTina HeroldSiegfried G PriglingerWolfgang J MayerPublished in: Journal of ophthalmology (2020)
The efficacy of the treatment of PCME in vitrectomized eyes seems to be affected by baseline BCVA, the absence of SRF, and the indication for surgery. Naïve status appears not to play any significant role in the prediction of BCVA. This trial is registered with DRKS00018955.
Keyphrases
- optical coherence tomography
- diabetic retinopathy
- minimally invasive
- cataract surgery
- optic nerve
- coronary artery bypass
- study protocol
- patients undergoing
- low dose
- clinical trial
- age related macular degeneration
- vascular endothelial growth factor
- phase iii
- randomized controlled trial
- high dose
- phase ii
- acute coronary syndrome
- percutaneous coronary intervention
- coronary artery disease
- combination therapy
- double blind